JENNIFER FITZGERALD: Open Payments
NPI 1730596362 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,176 in 124 payments from 26 companies in 2025. Trend: 2023 $2,470 · 2024 $2,324 · 2025 $2,176
Food & beverage: $2,176
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $407 |
| GlaxoSmithKline, LLC. | 12 | $214 |
| Medtronic, Inc. | 2 | $184 |
| Novo Nordisk Inc | 11 | $168 |
| AstraZeneca Pharmaceuticals LP | 4 | $166 |
| PFIZER INC. | 8 | $165 |
| Lilly USA, LLC | 12 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $117 |
| Inspire Medical Systems, Inc. | 3 | $81 |
| ABIOMED | 3 | $52 |
Products named: TRELEGY ELLIPTA, SYMPLICITY G3, AIRSUPRA, VRAYLAR, NURTEC ODT, Kerendia, QULIPTA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
